Campbell & CO Investment Adviser LLC Takes $4.07 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Campbell & CO Investment Adviser LLC purchased a new stake in UnitedHealth Group valued at approximately $4.07 million, acquiring 7,774 shares in the first quarter.
• UnitedHealth Group reported earnings per share of $4.08 for the last quarter, missing estimates by $0.37, despite a revenue increase of 12.9% year-over-year.
• The company declared a quarterly dividend of $2.21, with an annualized yield of 2.9%, set to be paid to shareholders of record.

Campbell & CO Investment Adviser LLC purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 7,774 shares of the healthcare conglomerate's stock, valued at approximately $4,072,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Quantitative Investment Management LLC bought a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $31,706,000. AIMZ Investment Advisors LLC increased its holdings in UnitedHealth Group by 0.8% during the first quarter. AIMZ Investment Advisors LLC now owns 5,578 shares of the healthcare conglomerate's stock valued at $2,922,000 after buying an additional 47 shares during the period. Smartleaf Asset Management LLC grew its holdings in UnitedHealth Group by 12.1% in the first quarter. Smartleaf Asset Management LLC now owns 8,592 shares of the healthcare conglomerate's stock worth $4,434,000 after purchasing an additional 928 shares during the last quarter. Bahl & Gaynor Inc. grew its holdings in shares of UnitedHealth Group by 17.7% during the first quarter. Bahl & Gaynor Inc. now owns 277,048 shares of the healthcare conglomerate's stock valued at $145,104,000 after buying an additional 41,753 shares during the last quarter. Finally, Biondo Investment Advisors LLC grew its holdings in shares of UnitedHealth Group by 4.7% during the first quarter. Biondo Investment Advisors LLC now owns 19,242 shares of the healthcare conglomerate's stock valued at $10,078,000 after buying an additional 861 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $307.0980 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm's fifty day simple moving average is $288.39 and its 200-day simple moving average is $388.53. The firm has a market capitalization of $278.13 billion, a price-to-earnings ratio of 13.31, a PEG ratio of 1.98 and a beta of 0.43. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's quarterly revenue was up 12.9% on a year-over-year basis. During the same period last year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group's payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on UNH shares. Wall Street Zen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a report on Wednesday. Truist Financial dropped their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. Wolfe Research decreased their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Finally, HSBC reiterated a "reduce" rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Fifteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $365.38.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.